063160.KS
CKD Bio Corp.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 12,350.00
−0.24%Next report
Analyst consensus
- Next report date
- Nov 18, 2026
- EPS estimate
- —
- Revenue estimate
- KRW 44.8B
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- -KRW 985
- EPS estimate
- —
- Revenue actual
- KRW 41.1B
- Revenue estimate
- KRW 44.8B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- 0
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 31, 2026 | — | -KRW 985 | — | KRW 41.1B |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 18, 2026